what is ghk-cu peptide 89030-95-5 Gly-His-Lys-Cu Copper Tripeptide-1; Prezatide copper GHK-Cu Topical Copper Peptide Serum

The synthetic version used in laboratory research replicates this natural sequence and is produced under controlled manufacturing conditions to research-grade purity standards

the dosing figures on this page nonetheless describe published laboratory studies and investigational clinical trials only, not a protocol for use

PMID 21030672

Understanding BPC-157 Micro-Dosing The Science Behind Lower Doses Chronic Conditions That Respond Well Micro-Dosing vs Standard Protocols Optimal Micro-Dosing Protocols Injectable Administration Techniques Combining with Other Therapies Timeline and What to Expect Cycling Strategies for Long-Term Use Quality and Sourcing Considerations Frequently Asked Questions Glossary of Terms References Understanding BPC-157 Micro-Dosing BPC-157 stands for Body Protection Compound 157, a synthetic peptide containing 15 amino acids derived from a protective protein naturally found in human gastric juice

For neuroprotection protocols, standard dosing uses 0.25 to 0.5 mg daily via subcutaneous or oral administration

These formulations often use microsphere or other sustained-release technologies to extend drug release over weeks or months